Skip to main content
  • Home

Recent Posts by our contributor, joseph mansour

FDA approves breakthrough breast cancer drug
Mon, 06/11/2012 - 2:57pm

In an unprecedented breakthrough in breast cancer research, the FDA approved a new drug that should improve on the treatment of one of the most deadly forms of breast cancer to date, HER2-positive.

Alzheimer's drug disappoints
Wed, 08/08/2012 - 3:00pm

Pfizer and Johnson & Johnson stated on Monday that they have ended the development of an intravenous drug that was supposed to aid patients with Alzheimer’s disease, according to Bloomberg.com.

Follow us:
  • facebook
  • twitter
  • YouTube

 

  • Popular
  • Recent
  • Tags
  • Alzheimer's drug disappoints

    • Aug 8, 2012
  • FDA, companies to study metal-on-metal implant effects

    • Jul 2, 2012
  • Johnson & Johnson could learn a thing or two from Smith & Nephew

    • Jun 6, 2012
  • Canadian study shows Actos doubles bladder cancer risk

    • Jun 8, 2012
  • Warfarin alternatives create concerns

    • Jun 22, 2012
  • Medicaid patients sue D.C. over drug denials

    • Jul 9, 2012
  • FDA issues warning after codeine kills children post-surgery

    • Aug 16, 2012
  • Artificial retina gives sight to blind mice

    • Aug 16, 2012
  • Lucentis approved for diabetic macular edema

    • Aug 14, 2012
  • Mayo Clinic: Patients in the dark about prescriptions

    • Aug 9, 2012
  • Hospital's plan to prevent painkiller abuse

    • Aug 8, 2012
  • Alzheimer's drug disappoints

    • Aug 8, 2012
blood clots bladder cancer Design femur fractures Bayer Johnson & Johnson Johnson & Johnson lawsuits internal bleeding GlaxoSmithKline Roche TVM Fen-Phen Zimmer lorcaserin generic Medicaid Accutane Washington kidney problems Travel Xarelto Warfarin Avaira Urban stroke Belviq diet drug deep vein thrombosis breast cancer regorafenib

More Dangerous Drug News

Lipitor Type 2 Diabetes Lawsuit

Get News Updates By Email

@ConsumerDrugRep Tweets

Archives

  • June 2011 (3)
  • September 2011 (1)
  • October 2011 (3)
  • November 2011 (5)
  • December 2011 (25)
  • January 2012 (8)
  • February 2012 (24)
  • March 2012 (20)
  • April 2012 (6)
  • May 2012 (12)

Pages

  • 1
  • 2
  • next ›
  • last »
Thursday, 26 May 2022
  • Subscribe by RSS
Consumer Drug Report
  • Tylenol
  • Miscellaneous
    • Avaira
  • Antidepressants
  • Fosamax
  • Pradaxa
  • Actos
  • Yaz
About Us

From side effects to recalls to pending lawsuits, Consumer Drug Report keeps you up to date with the latest information on pharmaceutical safety.

To submit questions or story ideas, please post on our Consumer Drug Report Facebook page,

tweet at us @ConsumerDrugRep, or

email us at news@consumer-drug-report.com.

Details

Home

About

Contact

Privacy

Sitemap 

Disclaimer

Categories
  • Actos
  • Antidepressants
  • Avaira
  • Fosamax
  • Miscellaneous
  • Pradaxa
  • Tylenol
  • Yaz

Brought to you by Spangenberg Shibley & Liber, LLP © 2012